An overview of the market for portable inhalers, looking at market shares, usefulness as tools for franchise protection and expansion. Patient and physician preferences are being analyzed as well as suitablility of molecules and inhaler types.

Scope

Summary of the advantages and disadvantages of the main types of portable inhaler devices

Market overview highlighting CFC-free and CFC-containing devices and devices delivering branded and generic molecules, based on 2007 IMS

Sales Data Overview of portable inhaler devices in non-pulmonary diseases, including inhaled insulin for the treatment of diabetes

Assessment of opportunities to use portable inhaler devices as key factors in a product's commercial success throughout its lifecycle.

Highlights

Although a direct link between the type of device and level of disease control has never been proven, the latter is possibly indirectly influenced by the respective device's ease of use, its airflow resistance and the patient's device preferences. There are still opportunities in the asthma/COPD market to gain market share by differentiating with an improved inhaler device.

One of such strategies would be to introduce a product line of different molecules in the same device model in order to give physicians the opportunity to minimize the scope for error on the patient side. Inhaled drugs are increasingly being developed for systemic use in non-pulmonary diseases. Reasons for this include improved patient acceptance and compliance and a faster onset of action. However, the commercial failure of Pfizer's inhaled insulin illustrates the difficulties in striking the right balance.

Reasons to Purchase

Understand key advantages and disadvantages of different types of portable inhaler devices

Identify future challenges for portable inhaler devices and best method of meeting these

Assess the respiratory market's segmentation and dynamics by device type and brand/generic split.



159 pages

Publication Date : April 2008